MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
October 30, 2020

ESMO Study Reviews Combination Treatment for T-cell Lymphoma

By Adam Hochron
Researchers looking at treatment for relapsed or refractory peripheral T-cell lymphoma described the current prognosis as “dismal”...
ESMO Study Reviews Combination Treatment for T-cell Lymphoma
October 28, 2020

FDA Applications Submitted for Upadacitinib as Atopic Dermatitis Treatment

By Adam Hochron
The manufacturer of upadacitinib has submitted applications to the FDA and European Medicines Agency to have the drug approved as a treatment for adults and adolescents with moderate to severe atopic dermatitis...
FDA Applications Submitted for Upadacitinib as Atopic Dermatitis Treatment
October 25, 2020

Tarloxotinib Exhibits Preliminary Efficacy in Patients With NSCLC, HER-2 Activating Mutations

By Cameron Kelsall, /alert Contributor
Tarloxotinib, a hypoxia-activated pan HER-2 tyrosine kinase inhibitor, showed promising antitumor activity and a tolerable safety profile in patients with non–small cell lung cancer...
Tarloxotinib Exhibits Preliminary Efficacy in Patients With NSCLC, HER-2 Activating Mutations
October 22, 2020

Remote Management Brings Heart Failure Therapy Closer to Guidelines

By Annette M. Boyle, /alert Contributor
Bringing treatment for patients with heart failure with reduced ejection fraction (HFrEF) more into line with guidelines can be achieved without more in-person visits with a cardiologist...
Remote Management Brings Heart Failure Therapy Closer to Guidelines
October 16, 2020

Top 5 Abstracts from ESMO 2020

By MD /alert 
Last month, researchers from around the globe met for the ESMO Virtual Congress 2020. The meeting, held virtually due to the ongoing pandemic...
Top 5 Abstracts from ESMO 2020
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Anti-IL-5 biologics effective for up to two years in severe asthma, but residual disease remains

By Marilynn Larkin NEW YORK (Reuters Health) - More than 80% of patients with severe asthma responded to anti-IL-5 biologics in a two-year follow-up study, but 69% experienced persistent airflow Read More »

Thousands of excess cancers among American Indians/Alaska Natives, especially in Southern Plains

By Marilynn Larkin NEW YORK (Reuters Health) - Liver, stomach, kidney, lung, colorectal and female breast cancers have a higher incidence rate among American Indian/Alaska Native (AI/AN) populations Read More »

Home-based mobile guided cardiac rehab may be safe and beneficial

By Linda Carroll (Reuters Health) - A six-month home-based mobile guided cardiac rehab program may offer a safe and moderately effective alternative for elderly patients who do not wish to participate Read More »

Social media disinformation campaigns tied to vaccine hesitancy

By Lisa Rapaport (Reuters Health) - Social media disinformation campaigns designed to cast doubt on the safety and effectiveness of vaccines are contributing to vaccine hesitancy and a meaningful drop Read More »

Fauci says first U.S. COVID-19 vaccines could ship late December or early January

By Julie Steenhuysen CHICAGO (Reuters) - If all goes well, the first doses of a safe and effective coronavirus vaccine will likely become available to some high-risk Americans in late December or Read More »

Spain enters 6-month state of emergency to tackle pandemic

By Elena Rodriguez and Joan Faus MADRID (Reuters) - Spain will be under a state of emergency until early May, giving regions legal backing to decide curfews and restrict travel to try and contain Read More »

Men with localized prostate cancer have reduced long-term quality of life

By Will Boggs MD NEW YORK (Reuters Health) - Men with localized prostate cancer, especially those who undergo radical prostatectomy, have generally worse long-term self-reported quality of life than Read More »

INSIGHT-Make Science Great Again: U.S. researchers dream of life after Trump

By Valerie Volcovici and Sharon Bernstein WASHINGTON, D.C. (Reuters) - From his lab in Toulouse, France, Benjamin Sanderson models the range of extreme risks to humans from climate change, research he Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information